ADP receptors and clinical bleeding disorders

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 10, 1999, Pages 2281-2285

  Cattaneo, Marco ^a   Gachet, Christian ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b INSERM   (France)

Author keywords

Adenosine diphosphate; Bleeding disorders; Platelets; Purino receptors; Thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RECEPTOR; CALCIUM ION; CLOPIDOGREL; DESMOPRESSIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SUBUNIT; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; THROMBOCYTE RECEPTOR; TICLOPIDINE; UNCLASSIFIED DRUG;

BLEEDING DISORDER; CALCIUM TRANSPORT; DRUG MECHANISM; EXPERIMENTAL MODEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR DYNAMICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFECT; REVIEW; THROMBOCYTE ACTIVATION;

EID: 0032858002     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.10.2281     Document Type: Review

References (35)

1. Mills DC. ADP receptors on platelets. Thromb Haemost. 1997;76: 835-856.
2. Gachet C, Hechler B, Leon C, Vial C, Leray C, Ohlmann P, Cazenave JP. Activation of ADP receptors and platelet function. Thromb Haemost. 1997;78:271-275.
3. Bhagwat SS, William M. P2 purine and pyrimidine receptors: emerging superfamilies of G-protein-coupled and ligand-gated ion channel receptors. Eur J Med Chem. 1997;32:183-193.
4. Rao AK. Congenital disorders of platelet function. In: Colman RW, Rao AK, eds. Platelets in Health and Disease: Hematol/Oncol Clin North Am. 1990;4:65-82.
5. Schrör K. The basic pharmacology of ticlopidine and clopidogrel. Platelets. 1993;4:252-261.
6. Humphries RG, Robertson MJ, Leff P. A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends Pharmacol Sci. 1995;16:179-181.
7. Cattaneo M. Hereditary defect of the platelet ADP receptor(s). Platelets. 1998;8:161-164.
8. Falcon CR, Cattaneo M, Ghidoni A, Mannucci PM. The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionised calcium. Thromb Haemost. 1993; 70:389-392.
9. Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol. 1975;228:1757-1765.
10. Offermanns S, Toombs CF, Hu YH, Simon MI. Defective platelet activation in Gαq-deficient mice. Nature. 1997;389:183-186.
11. Daniel JL, Dangelmaier CA, Jin J, Ashby B, Smith JB, Kunapuli SP. Molecular basis for ADP-induced platelet activation, I: evidence for three distinct ADP receptors on human platelets. J Biol Chem. 1998;273: 2024-2029.
12. Savi P, Beauverger P, Labouret C, Delfaud M, Salel V, Kaghad M, Herbert JM. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett. 1998;422:291-295.
13. 1 receptor is necessary for ADP-induced platelet aggregation. Blood. 1998;92:152-159.
14. Geiger J, Honig-Liedl P, Schanzenbacher P, Walter U. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur J Pharmacol. 1998;351:235-246.
15. Gachet C, Cattaneo M, Ohlmann P, Hechler B, Lecchi A, Chevalier J, Cassel D, Mannucci PM, Cazenave J-P. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol. 1995;91:434-444.
16. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood. 1992;80:2787-2796.
17. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 1993;324:219-223.
18. 1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett. 1997;403:26-30.
19. 1 receptor: similarities with the platelet ADP receptor. Mol Pharmacol. 1998;53:727-733.
20. Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. II: the P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem. 1998; 273:2030-2034.
21. Jantzen H-M, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds EE, Conley PB. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb Haemost. 1999;81:111-117.
22. 1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation. Thromb Haemost. 1991;81:775-781.
23. 1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol. 1998;103:858-866.
24. 1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost. 1997;78:1500-1504.
25. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A. 1998;95:8070-8074.
26. Nurden P, Savi P, Heilmann E, Bihour C, Herbert JM, Maffrand JP, Nurden A. An inherited bleeding disorder linked to a detective interaction between ADP and its receptor on platelets. J Clin Invest. 1995;95:1612-1622.
27. Cattaneo M, Zighetti ML, Lombardi R, Lecchi A, Gachet C, Cazenave J-P, Mannucci PM. Platelets from a patient heterozygous for the deficiency of 2 MeS-ADP binding sites have a secretion defect. Eur J Clin Invest. 1997;27(suppl 1):A23. Abstract.
28. Levy-Toledano S, Maclouf J, Rosa JP, Gallet C, Valles G, Nurden P, Nurden AT. Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptors on platelets. Thromb Haemost. 1998;80:463-468.
29. Humbert M, Nurden P, Bihour C, Pasquet JM, Winckler J, Heilmann E, Savi P, Herbert JM, Kunicki TJ, Nurden AT. Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation. Arterioscler Thromb Vasc Biol. 1996;16:1532-1543.
30. Savi P, Artçanuthurry V, Bornia J, Grelac F, Maclouf J, Levy-Toledano S, Herbert J-M. Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets. Br J Haematol. 1997;97:185-191.
31. 33P]2 MeS-ADP binding sites on platelets with secretion detect, normal granule stores and normal thromboxane A2 production: evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Thromb Haemost. 1997;77:986-990.
32. Polgar J, Eichler P, Greinacher A, Clemetson KJ. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/ aggregation induced by sera from heparin-induced thrombocytopenia patients. Blood. 1998;91:549-554.
33. Cattaneo M, Canciani MT, Lecchi A, Kinlough-Rathbone RL, Packham MA, Mannucci PM, Mustard JF. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood. 1990;75: 1081-1086.
34. Cattaneo M, Zighetti ML, Lombardi R, Mannucci PM. Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP. Br J Haematol. 1994;88: 826-829.
35. Cattaneo M, Randi AM, Canciani MT, Lecchi A, Mannucci PM. Role of ADP in platelet aggregation and fibrinogen binding induced by prostaglandin endoperoxides: studies in a patient with selective defect of ADP-induced platelet aggregation. In: Jamieson GA, ed. Platelet Membrane Receptors: Molecular Biology, Immunology, Biochemistry and Pathology. New York, NY: Alan R. Liss; 1988:279-283.